Comparison of Flexible Fibreoptic Scope With Pentax AWS Videolaryngoscope for Ease of Intubation During Awake Intubation
NCT ID: NCT02614924
Last Updated: 2016-08-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2012-11-30
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Awake Endotracheal Intubation in Cervical Injury
NCT05619965
Pentax Airway Scope (AWS) Intubation
NCT00667693
Comparison of the Pentax AWS® With the Macintosh Laryngoscopic Intubation in Obstructive Sleep Apnea Syndrome Patients
NCT01428570
Randomised Controlled Trial of Intubation, Comparing Pentax AWS Against Macintosh Laryngoscope.
NCT01029756
Airtraq Versus Fiberoptic for Awake Tracheal Intubation
NCT03539185
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The incidence of difficult tracheal intubation during routine anaesthesia in general population is around 3-18% although it varies \[1\]. Awake intubation is considered in situations such as in patients with a known or suspected difficult airway, upper airway obstruction. Awake intubation under local anaesthesia and sedation also indicated cervical spine disease in view of minimising movement of cervical spine \[2\]. Any technique tracheal intubation under general anaesthesia involves some degree of movement at cervical spine. Direct laryngoscopy and tracheal intubation in under general anaesthesia is usually achieved by flexion of lower cervical spine and extension at atlanto-occipital joint \[3\]. Difficulties or failure in airway management is still an important factor in morbidity and mortality related to anaesthesia.
In recent years videolaryngoscopes have been used as an alternative to traditional fibreoptic scope in the management of difficult airway \[4,7,8\]. Over last 2 years in our institution the investigators have used Pentax AWS videolaryngoscope for awake intubation in patients presenting for surgery with cervical spine disease \[9, 10\].
However there has not been any study comparing flexible fibreoptic scope with video laryngoscopes in the management of difficult airway in awake patients. The proposed benefits of Pentax AWS (Airway scope) over a flexible fibreoptic scope include ease of setting up the device, less complexity of the skill, therefore easy to learn the skill and availability of disposable devices minimising the need for cleaning and disinfecting the device.
Pentax AWS with PBlade videolaryngoscope has a unique target symbol displayed on the monitor, which highlights the intended path of the endotracheal tube. The Pentax PBlade is a single patient use device that minimizes the risk of infection.
Study Design and Methods: Randomised Controlled Trial
Patient Selection:
Forty patients presenting for cervical spine surgery under general anaesthesia and requiring oral endotracheal intubation will be invited to take part in the study. During preoperative visit, a patient information sheet will be given to the patients meeting the eligible criteria. The patient will be given adequate time to read the information sheet and any queries will be answered. Wherever possible, suitable patients will be identified in the preoperative assessment clinic. A detailed airway assessment will be performed by one of the investigator.
Whenever possible, when patients are admitted the night before their operation, they should be seen by an Anaesthetist and given the study information.
Techniques of Anaesthesia:
After securing intravenous cannulation and instituting standard anaesthetic monitoring with ECG, pulse oximetry and non-invasive blood pressure monitoring, conscious sedation will be started using target controlled infusion of remifentanil and 1 mg of midazolam. At this stage numbered opaque envelope will be opened to choose one of the two devices. The tongue, oropharynx and larynx will be anaesthetised using 4% lignocaine using Mckenzie technique (nebulisation of local anaesthetic through 20 G cannula).
Adequate anaesthesia of upper airway will be checked by inserting an appropriately sized oropharyngeal airway (if the patient can tolerate well, the airway is anesthetised adequately, if not further local anaesthetic is administered to the oropharynx). After confirming adequate anaesthesia of upper airway, the chosen device will be inserted into the oropharynx. Further local anaesthesia to the base of the tongue, larynx and trachea will be administered using spray as you go technique where the local anaesthetic administered through the device whilst gradually advancing the device towards larynx. After confirming the position of the tracheal tube and testing the gross neurological state of all 4 limbs, general anaesthesia will be induced.
Data Collection:
During the procedure of laryngoscopy and endotracheal intubation, a modified intubation difficulty score (IDS) would be developed based on the parameter recorded. Along with intubation difficulty score other parameters compared include: time taken to complete the process of intubation, anaesthetist rating of intubation and patient rating of procedure.
The following parameter would be recorded and scored:
1. Coughing episode: 0 no cough 1 if mild cough, 2 if moderate cough, 3 if severe cough.
2. Gagging episode: 0 no gagging, 1 if mild gag, 2 if moderate gag, 3 if severe gag.
3. Ease of insertion of device: 0 easy, 1 if mild difficulty 2 if moderately difficulty, 3 very difficult.
4. Laryngoscope view based on the percentage of the glottis visualised 0 if 75-100% view, 1 if 50-75% view, 2 if \<50% view, 3 no VC visible.
5. Tube rotation or manipulation, 0 if no rotation required, 1 if rotation required
6. Airway trauma, 0 no trauma, 1 if minor injury (lip), 2 if oro-pharyngeal injury/ bleeding. 3, bleeding requiring use of suction
7. Stress response based on heart rate and blood pressure (0 if stable, 1 if increased more than 20%)
8. Overall patients' tolerance as judged by the Anaesthetists (visual analogue score of 0 to 100mm)
9. Overall impression from patient on a visual analogue scale (visual analogue score of 0 to 100mm)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flexible fibre-optic scope
Randomly allocated to fibreoptic group
Flexible fibreoptic scope
Patient intubated using fibreoptic scope
Pentax AWS videolaryngoscope
Patient intubated using Pentax AWS videolaryngoscope
Pentax AWS videolaryngoscope
Randomly allocated Pentax AWS videolaryngoscope
Flexible fibreoptic scope
Patient intubated using fibreoptic scope
Pentax AWS videolaryngoscope
Patient intubated using Pentax AWS videolaryngoscope
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flexible fibreoptic scope
Patient intubated using fibreoptic scope
Pentax AWS videolaryngoscope
Patient intubated using Pentax AWS videolaryngoscope
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with anticipated difficult airway include those with Mallampati class 3 and above, other signs such as limited neck movement and limited jaw protrusion will be include in the study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospitals Coventry and Warwickshire NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RD098211
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.